Jci_page_head_homepage_01 Jci_page_head_homepage_02
Li Chen, Magali Periquet, Xu Wang, Alessandro Negro, Pamela J. McLean, Bradley T. Hyman, Mel B. Feany
Published in Volume 119, Issue 11
J Clin Invest. 2009; 119(11):3257–3265 doi:10.1172/JCI39088
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
α-Synuclein toxicity correlates with accumulation of soluble high-molecular-weight oligomers.

(A) Representative immunoblot of soluble fractions from brain homogenates run on a 4%–12% gradient gel shows increased oligomer formation in flies expressing α-synS129D and decreased oligomer formation in flies expressing α-synS129A. Aliquots of the same protein preparations were loaded on a separate 10%–20% gel to visualize monomeric α-synuclein and tubulin. Control genotype: elav-GAL4. (B) Quantitative analysis of oligomer formation using densitometry. Values represent mean ± SEM of 3 independent experiments. Single asterisk indicates the significantly increased accumulation of high-molecular-weight species in flies expressing α-synS129D (*P < 0.01, multivariant ANOVA with supplementary Newman-Keuls test) at 10 days. Double asterisks indicate the significantly decreased accumulation in α-synS129A flies at 20 days (**P < 0.01, multivariant ANOVA with supplementary Newman-Keuls test). (C) Coexpression of the serine kinase Gprk2 with α-synWT increases high-molecular-weight α-synuclein species. Flies were 10 days old.